Japan Tissue Engineering Co.,Ltd. [7774.T]
TOKYO, Jun 19 (Pulse News Wire) – Japan Tissue Engineering CO.,LTD. (7774.T) decided today to establish a subsidiary in Europe aimed at expanding its research tissue product lines.
The move comes in response to logistical challenges faced due to the limited shelf life of live human cell products and recent geopolitical instability. The newly established subsidiary, Japan Tissue Engineering Europe GmbH, will be located in Heidelberg, Germany, providing strategic advantages for efficient distribution across Europe. With an initial capital of €25,000 (approximately ¥4.6 million), the subsidiary plans to develop, manufacture, and sell scientific products and experimental/research materials tailored for research purposes. The company expects the subsidiary to begin operations within 2026, addressing previous limitations related to transportation risks and storage constraints. Key executives from Japan Tissue Engineering will play significant roles in the new entity, with one executive serving as the representative director. The subsidiary's establishment marks a crucial step towards enhancing the company’s presence in the European market, particularly through partnerships with facilities equipped for necessary manufacturing equipment.
The subsidiary’s operational launch is scheduled for within the calendar year of 2026, aligning with the parent company’s fiscal year ending March 31. Major shareholder ratios indicate that Japan Tissue Engineering CO.,LTD. holds 100%. The subsidiary will operate independently but maintain close ties with the parent company, potentially leading to future transactions involving raw materials and other supplies. Looking ahead, the subsidiary is expected to join Japan Tissue Engineering’s consolidated financial statements beginning in the fiscal year ending March 2027. While the impact on the company’s performance for the fiscal year ending March 2027 is anticipated to be minor, Japan Tissue Engineering remains committed to disclosing any significant developments promptly.
🟢 Confidence: High AI-translated content.